Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Andelyn Biosciences, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Purespring Therapeutics, a biotech company, to accelerate the manufacture of their gene therapies for the treatment of ...
read more
Aldena Therapeutics, a private biotech company pioneering siRNA- based therapies for dermatological indications, has chosen PCI Pharma Services (PCI), a global contract development and manufacturing organization (CDMO) to formulate, package, and ...
read more
Avid Bioservices, Inc. , a biologics contract development and manufacturing organization (CDMO) announced that it has completed construction of CGMP manufacturing suites within its new, world-class cell and gene therapy (CGT) development and CGMP ...
read more
According to DataHorizzon Research, the Active Pharmaceutical Ingredients (API) Market size was valued at USD 151.2 Billion in 2022 and is expected to reach USD 346.4 Billion by 2032 at a CAGR of 8.7%.
read more
Thursday, October 26, 2023
Dipharma Francis S.r.l. (Dipharma), a CDMO and global producer of APIs, announced that their manufacturing facility situated in Caronno Pertusella, near Milan, Italy, has been awarded the Good Manufacturing Practice (GMP) certification - CBPF (...
read more
Thursday, October 26, 2023
Catawba Research, a clinical research organization announced changes to its executive leadership team. Catawba’s Founder, Zaidoon A. Al-Zubaidy, is transitioning his day-to-day leadership responsibilities to Dr. Andy Silverman. Al-Zubaidy will become...
read more
Elligo Health Research announced a partnership with Avallano to launch myTrialsConnect a scalable research community powered by artificial intelligence (AI), that was built to serve patients, providers, sites, and the biopharma industry.
read more
RLS Radiopharmacies, the only Joint Commission-accredited radiopharmacy network in the U.S., announced it is expanding its business operations with the addition of radiopharmaceutical contract development and manufacturing (rCDMO) services.
read more
L2P Research, LLC, a preclinical CRO, announced the award of a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).
read more
Phastar, a global biometrics contract research organization (CRO), announced it is offering pro bono support to Medicines Development for Global Health (MDGH), a not-for-profit organization developing medicines for neglected diseases primarily ...
read more
Aragen, a Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, announced that it was setting up a new biologics manufacturing facility in Bangalore, India.
read more
Pharmascience Inc. announced a major expansion of its sterile injectable manufacturing facility in Candiac, Québec, supported by partners with Innovation, Science and Economic Development Canada's Strategic Innovation Fund and by the Government of ...
read more
Wednesday, November 01, 2023
Altasciences announced the completion of its newly expanded, 8,000-square-foot space, which includes a test material department, features state-of-the-art equipment and forty-eight workbenches, with a vast range of services, including ligand binding ...
read more
Wednesday, November 01, 2023
Resolian, a global bioanalytical contract research organization (CRO) specializing in drug metabolism and pharmacokinetics for small and large molecules, has acquired Denali Medpharma, a leading China-based bioanalytical CRO.
read more
Friday, November 03, 2023
Noramco, a prominent worldwide producer of active pharmaceutical ingredients (APIs), renowned for its proficiency in controlled substances, has successfully concluded the acquisition of the Cambrex Drug Product Business Unit, previously recognized as...
read more